Science Immunology

Science Immunology
Title	Science Immunology
Discipline	Immunology
Publisher	American Association for the Advancement of Science
Country	United States
Frequency	Monthly
Established	2016

Contents

Science Immunology

Science Immunology is a peer-reviewed scientific journal published by the American Association for the Advancement of Science that focuses on research in immunology, host–pathogen interactions, and translational immune medicine. The journal publishes original research, reviews, and commentaries that bridge basic science and clinical practice, engaging communities aligned with institutions such as the National Institutes of Health, Harvard Medical School, and the Johns Hopkins University School of Medicine. Contributors and readers often include investigators affiliated with organizations like the Centers for Disease Control and Prevention, Massachusetts Institute of Technology, and the University of Oxford.

Introduction

Science Immunology disseminates studies on adaptive immunity, innate immune responses, immune regulation, and immunopathology, serving researchers at centers including Stanford University, Cold Spring Harbor Laboratory, and the Salk Institute. Its scope overlaps with work from consortia and programs such as the Human Genome Project, the Human Microbiome Project, and initiatives at the Wellcome Trust and Howard Hughes Medical Institute. The journal situates findings alongside clinical frameworks from hospitals like Mayo Clinic and Cleveland Clinic and policy dialogues involving the World Health Organization and the European Commission.

Science Immunology was launched within the portfolio of the Science (journal) family to address increasing specialization within fields emerging after milestones like the completion of the Human Genome Project and technological advances at facilities such as the Broad Institute and the European Molecular Biology Laboratory. Early editorial leadership included scientists with affiliations to institutions such as Yale University, University of California, San Francisco, and the National Institute of Allergy and Infectious Diseases. The journal's development mirrored broader shifts in funding and collaboration observed in programs like the National Cancer Institute cooperative groups and public–private partnerships exemplified by the Bill & Melinda Gates Foundation.

Articles in Science Immunology frequently elucidate processes involving lymphocyte development traced to seminal work from laboratories at The Rockefeller University, University of Cambridge, and the Max Planck Society. Mechanistic studies reference signaling pathways discovered in research hubs such as the Salk Institute, Massachusetts General Hospital, and Fred Hutchinson Cancer Center, connecting to molecule-focused findings from teams at MIT, University of Pennsylvania, and Cold Spring Harbor Laboratory. Investigations include antigen presentation studies rooted in immunology traditions at Karolinska Institutet, dendritic cell biology with ties to Institut Pasteur, and cytokine network characterization building on work from Imperial College London and Johns Hopkins University.

Science Immunology highlights methodological advances including single-cell genomics developed at places like the Broad Institute, cryo-electron microscopy work advanced by groups at MRC Laboratory of Molecular Biology, and in vivo imaging techniques refined at University of California, Berkeley and Max Planck Institute for Biophysical Chemistry. Animal models reported often involve collaborations with facilities such as the Jackson Laboratory, the European Molecular Biology Laboratory animal units, and the Wellcome Sanger Institute pipelines. Computational immunology papers integrate algorithms and datasets from projects linked to Google DeepMind, the Allen Institute for Immunology, and consortiums associated with European Research Council grants.

The journal publishes translational studies bridging bench and bedside with clinical partners including Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and the Fred Hutchinson Cancer Research Center. Work on vaccine development often references collaborations with industry participants like Moderna, Pfizer, and AstraZeneca, and regulatory contexts involving agencies such as the Food and Drug Administration and the European Medicines Agency. Immunotherapy reports connect to trials run through networks affiliated with the National Cancer Institute, cooperative groups such as SWOG Cancer Research Network, and international consortia including the International AIDS Vaccine Initiative.

Current themes in Science Immunology include systems-level immune profiling influenced by projects at the Human Cell Atlas, tumor immunology building on discoveries at Dana-Farber Cancer Institute and Memorial Sloan Kettering, and mucosal immunology with contributions from University College London and the Institute of Tropical Medicine Antwerp. Emerging areas covered include neoantigen prediction informed by work at the European Bioinformatics Institute, microbiome–immune interactions studied by teams at the University of Chicago and ETH Zurich, and cross-disciplinary efforts linking immunology to neurobiology through collaborations with Massachusetts General Hospital and Stanford University School of Medicine. Global health and pandemic preparedness content draws on experience from the Centers for Disease Control and Prevention, the World Health Organization, and research programs supported by the Wellcome Trust and the Bill & Melinda Gates Foundation.

Category:Scientific journals